{{medical}}
{{Drugbox
| Watchedfields = changed
| verifiedrevid = 464377204
| IUPAC_name = 5-(4-chlorophenyl)-6-ethyl- 2,4-pyrimidinediamine
| image = Pyrimethamine2DACS.svg
| image2 = Pyrimethamine-3D-balls.png
| width = 150px
<!--Clinical data-->
| pronounce = {{IPAc-en|ˌ|p|ɪr|ᵻ|ˈ|m|ɛ|θ|ə|m|ɪ|n}}
| tradename = Daraprim
| Drugs.com = {{drugs.com|monograph|Pyrimethamine}}
| MedlinePlus = a601050
| pregnancy_AU = B3
| pregnancy_US = C
| legal_AU = S4
| legal_CA = Rx-only
| legal_UK = POM
| legal_US = Rx-only
| routes_of_administration = By mouth
<!--Pharmacokinetic data-->
| bioavailability = well-absorbed
| protein_bound = 87%
| metabolism = [[Liver|Liver]]
| elimination_half-life = 96 hours
| excretion = [[Kidney|Kidney]]
<!--Identifiers-->
| IUPHAR_ligand = 4800
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 58-14-0
| ATC_prefix = P01
| ATC_suffix = BD01
| ATC_supplemental = <br/>{{ATCvet|P51|AX51}} (combinations)
| PubChem = 4993
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00205
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 4819
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = Z3614QOX8W
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D00488
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 8673
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 36
| PDB_ligand = CP6
<!--Chemical data-->
| C=12 | H=13 | Cl=1 | N=4
| molecular_weight = 248.71 g/mol
| SMILES = Clc2ccc(c1c(nc(nc1CC)N)N)cc2
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C12H13ClN4/c1-2-9-10(11(14)17-12(15)16-9)7-3-5-8(13)6-4-7/h3-6H,2H2,1H3,(H4,14,15,16,17)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = WKSAUQYGYAYLPV-UHFFFAOYSA-N
| melting_point = 233
| melting_high = 234
}}
'''乙胺嘧啶'''（{{lang-en|Pyrimethamine}}）商品名叫'''达拉匹林'''（{{lang|en|Daraprim}}），是一种可以与[[甲酰四氢叶酸|甲酰四氢叶酸]]治疗一起弓形虫病和等孢球虫病的药物<ref name=":0">{{Cite news|url=http://www.drugs.com/monograph/pyrimethamine.html|title=Pyrimethamine Monograph for Professionals - Drugs.com|newspaper=Drugs.com|accessdate=2018-07-14|language=en-US}}</ref><ref>{{Cite book|url=https://www.worldcat.org/oclc/922644939|date=2014|publisher=Jones & Bartlett Learning|isbn=1284057569|location=Sudbury|chapter=Tarascon pocket pharmacopoeia 2015 deluxe lab coat edition.|oclc=922644939}}</ref>。还与[[氨苯碸|氨苯砜]]一起用于预防HIV / AIDS患者的肺孢子虫肺炎（PCP）<ref name=":0" />。以前被用于治疗疟疾，但由于耐药性而不再推荐使用<ref name=":0" />。乙胺嘧啶是通过口服服用<ref name=":0" />。

常见的副作用包括胃肠不适，严重的过敏反应，[[骨髓抑制|骨髓抑制]]<ref name=":0" />。[[葉酸缺乏症|叶酸不足]]造成贫血的人不应该使用它<ref name=":0" />。也有人担心它可能会增加患癌症的风险<ref name=":0" />。但目前尚不清楚乙胺嘧啶是否对婴儿产生安全疑虑<ref>{{Cite news|url=http://www.drugs.com/pregnancy/pyrimethamine.html|title=Pyrimethamine (Daraprim) Use During Pregnancy|newspaper=Drugs.com|accessdate=2018-07-14|language=en-US}}</ref>。乙胺嘧啶被归类为叶酸拮抗剂。它的作用是抑制叶酸的代谢，从而抑制DNA的产生<ref name=":0" />。

乙胺嘧啶于1952年被发现，并在1953年开始医学使用<ref name=":0" /><ref>{{Cite book|url=https://www.worldcat.org/oclc/911613337|last=(1920-....).|first=Mouchet, Jean|last2=Sylvie.|first2=Manguin,|last3=Pierre.|first3=Carnevale,|date=[2014]|publisher=J. Libbey Eurotext|isbn=9782742009633|location=Montrouge|chapter=Biodiversity of malaria in the world|oclc=911613337}}</ref>。其属于[[世界衛生組織基本藥物清單|世界卫生组织基本药物清单]]，是卫生系统所需的最有效和最安全的药物<ref>{{Cite web|url=http://www.who.int/medicines/publications/essentialmedicines/EML_2015_FINAL_amended_NOV2015.pdf?ua=1|title=|accessdate=|author=|date=|publisher=}}</ref>。

== 临床应用 ==
乙胺嘧啶通常与[[磺酰胺|磺酰胺]]和[[甲酰四氢叶酸|甲酰四氢叶酸]]一起使用<ref>{{Cite book|url=https://www.worldcat.org/oclc/826673635|last=Australia.|first=Pharmaceutical Society of|date=2013|publisher=Australian Medicines Handbook|isbn=9780980579093|location=Adelaide, S. Aust.|chapter=Australian medicines handbook.|oclc=826673635}}</ref>。

临床用于治疗[[弓形虫病|弓形虫病]]，放线菌病和[[等孢球虫病|等孢球虫病]]，用于治疗和预防[[卡氏肺孢子虫肺炎|肺孢子虫肺炎]]。

=== 弓形虫病 ===
乙胺嘧啶与[[磺胺嘧啶|磺胺嘧啶]]联合用于治疗活动性弓形虫病。这两种药物分别与药物[[甲氧苄氨嘧啶|甲氧苄氨嘧啶]]和磺胺甲恶唑 - 二氢叶酸还原酶和二氢蝶酸合成酶结合相同的酶靶。 

乙胺嘧啶也被用于参与治疗视网膜脉络膜炎的几项试验中<ref>{{Cite journal|title=Antibiotics versus no treatment for toxoplasma retinochoroiditis|url=https://www.ncbi.nlm.nih.gov/pubmed/27198629|last=Pradhan|first=Eli|last2=Bhandari|first2=Sanjeeb|date=2016-05-20|journal=The Cochrane Database of Systematic Reviews|issue=5|doi=10.1002/14651858.CD002218.pub2|pages=CD002218|issn=1469-493X|pmid=27198629|last3=Gilbert|first3=Ruth E.|last4=Stanford|first4=Miles}}</ref>。

=== 疟疾 ===
它主要治疗[[恶性疟原虫|恶性疟原虫]]（Plasmodium falciparum），也对[[間日瘧原蟲|间日疟原虫]]（Plasmodium vivax）有效<ref>{{Cite web|url=http://about.medicinescomplete.com/#/content/martindale/1389-y|title=Access leading drug and healthcare references - MedicinesComplete|accessdate=2018-07-14|work=MedicinesComplete|language=en-GB}}</ref>。由于耐药性恶性疟原虫的出现，现在很少使用乙胺嘧啶。与长效磺酰胺如磺胺嘧啶联合使用时用途广泛，例如凡西达，尽管对这种联合用药的耐药性正在增加。

== 历史 ==
诺贝尔奖获得者美国科学家[[Gertrude_Elion|Gertrude Elion]]在[[Burroughs-Wellcome|Burroughs-Wellcome]]（现为GlaxoSmithKline的一部分）开发了此药以治疗疟疾<ref>{{Cite book|url=https://www.worldcat.org/oclc/879552742|last=M.)|first=Vasudevan, D. M. (Damodaran|last2=Kannan.|first2=Vaidyanathan,|isbn=9789350905302|edition=Seventh edition|location=New Delhi|chapter=Textbook of biochemistry for medical students.|oclc=879552742}}</ref>。乙胺嘧啶自1953年开始生产<ref>{{Cite web|url=https://www.washingtonpost.com/news/to-your-health/wp/2015/09/21/ceo-of-company-that-raised-the-price-of-old-pill-hundreds-of-dollars-overnight-calls-journalist-a-moron-for-asking-why/|title=CEO who raised price of old pill more than $700 calls journalist a ‘moron’ for asking why|accessdate=2018-07-14|last=https://www.facebook.com/arianaeunjung.cha|work=Washington Post|language=en}}</ref>。2010年，[[葛蘭素史克|葛兰素史克]]将Daraprim的营销权出售给CorePharma。 Impax Laboratories于2014年寻求收购CorePharma，并于2015年3月完成了收购，包括Daraprim<ref>{{Cite news|url=http://www.nytimes.com/2015/09/21/business/a-huge-overnight-increase-in-a-drugs-price-raises-protests.html|title=Drug Goes From $13.50 a Tablet to $750, Overnight|accessdate=2018-07-14|language=en}}</ref>。2015年8月，[[图灵制药公司|图灵制药公司]]购买了专利权<ref>{{Cite web|url=http://www.forbes.com/forbes/welcome/?toURL=https://www.forbes.com/sites/johnlamattina/2015/09/21/heres-a-way-for-pharma-to-prevent-outrageous-generic-price-increases-and-help-its-reputation/&refURL=https://en.wikipedia.org/&referrer=https://en.wikipedia.org/|title=Forbes Welcome|accessdate=2018-07-14|work=www.forbes.com|language=en}}</ref>。

==参考来源==
<references />

{{Chromalveolate antiparasitics}}

[[Category:抗疟疾药|Category:抗疟疾药]]
[[Category:二氢叶酸还原酶抑制剂|Category:二氢叶酸还原酶抑制剂]]
[[Category:嘧啶|Category:嘧啶]]
[[Category:氯代芳烃|Category:氯代芳烃]]
[[Category:芳香胺|Category:芳香胺]]
[[Category:世界卫生组织基本药物|Category:世界卫生组织基本药物]]